Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Harmony Biosciences Holdings (HRMY) EBIAT: 2019-2025

Historic EBIAT for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $50.9 million.

  • Harmony Biosciences Holdings' EBIAT rose 10.35% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.7 million, marking a year-over-year increase of 51.42%. This contributed to the annual value of $145.5 million for FY2024, which is 12.91% up from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' EBIAT is $50.9 million, which was up 27.88% from $39.8 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year EBIAT high stood at $87.9 million for Q3 2022, and its period low was -$9.6 million during Q3 2021.
  • Moreover, its 3-year median value for EBIAT was $38.5 million (2023), whereas its average is $37.3 million.
  • Data for Harmony Biosciences Holdings' EBIAT shows a peak YoY increase of 52,385.19% (in 2021) and a maximum YoY decrease of 603.93% (in 2021) over the last 5 years.
  • Harmony Biosciences Holdings' EBIAT (Quarterly) stood at $22.7 million in 2021, then skyrocketed by 113.56% to $48.5 million in 2022, then tumbled by 45.15% to $26.6 million in 2023, then skyrocketed by 85.95% to $49.5 million in 2024, then climbed by 10.35% to $50.9 million in 2025.
  • Its EBIAT was $50.9 million in Q3 2025, compared to $39.8 million in Q2 2025 and $45.6 million in Q1 2025.